# Trade Mark Journal No.2025/045 7 November 2025

## WO0000001859933 (9,42)

Office of origin: France

Date of International Registration:23 January 2025
Date of designation in the UK: 23 January 2025

International priority date claimed: 4 October 2024 (France) (5087675)

Class 9
  Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generation software.
Class 42
  SaaS for use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, antibody, protein, peptide, biological product and chemical product research and design, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage and machine learning.

ProteoGenix

Representative: Barker Brettell LLP, 100 Hagley Road, Edgbaston Birmingham B16 8QQ UNITED KINGDOM